Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
141.83B
Market cap141.83B
Price-Earnings ratio
19.23
Price-Earnings ratio19.23
Dividend yield
6.86%
Dividend yield6.86%
Average volume
45.06M
Average volume45.06M
High today
$25.24
High today$25.24
Low today
$24.78
Low today$24.78
Open price
$24.99
Open price$24.99
Volume
42.83M
Volume42.83M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.11
52 Week low$23.11

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $24.89. The company's market cap stands at 141.83B, with a P/E ratio of 19.23 and a dividend yield of 6.86%.

On 2026-06-23, Pfizer(PFE) stock moved within a range of $24.78 to $25.24. With shares now at $24.89, the stock is trading +0.4% above its intraday low and -1.4% below the session's peak.

Trading activity shows a volume of 42.83M, compared to an average daily volume of 45.06M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.

PFE News

TipRanks 19m
Option traders moderately bearish in Pfizer with shares down 0.74%

Option traders moderately bearish in Pfizer (PFE), with shares down 18c near $24.89. Options volume extremely heavy with 409k contracts traded and puts leading...

24/7 Wall St. 2h
Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn't make the cut. Grab the names FREE today . Novo Nordisk's US...

Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait
Benzinga 5h
Pfizer's Lung Cancer Drug Candidate Falls Short Overall, Shows Benefit In Select Patients

While the study missed its primary overall survival endpoint in the broader patient population, it showed encouraging signals in second-line patients. SigVie-0...

Pfizer's Lung Cancer Drug Candidate Falls Short Overall, Shows Benefit In Select Patients

Analyst ratings

59%

of 29 ratings
Buy
34.5%
Hold
58.6%
Sell
6.9%

More PFE News

Simply Wall St 8h
Pfizer Misses Main Goal For Lung Cancer Drug But Sees Subgroup Hope

Pfizer reported that its investigational cancer drug sigvotatug vedotin did not meet the primary endpoint in a pivotal Phase 3 trial in non small cell lung canc...

Pfizer Misses Main Goal For Lung Cancer Drug But Sees Subgroup Hope
24/7 Wall St. 24h
Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today . Lilly secured f...

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow
Benzinga 1d
Pfizer Stock Edges Lower Monday: What's Going On?

Pfizer stock is taking a breather. What’s ahead for PFE stock? What To Watch: Pfizer CFO Transition Impact Pfizer is leaning on continuity here: Guegan has spen...

Pfizer Stock Edges Lower Monday: What's Going On?
Nasdaq 1d
Pfizer Isn't Expecting to Make Any Big Acquisition in the Next Couple of Years, but It's Planning to Do This Instead

Key Points Pfizer has leaned on acquisitions in recent years to strengthen its growth prospects. Acquisitions, however, can add costs and lead to inefficiency...

Pfizer Isn't Expecting to Make Any Big Acquisition in the Next Couple of Years, but It's Planning to Do This Instead
Nasdaq 2d
Could Pfizer Stock Be Your Ticket to Generational Wealth?

Key Points Pfizer is one of the world's most respected pharmaceutical companies. Pfizer is working through a normal product cycle in the drug sector. 10 stoc...

Could Pfizer Stock Be Your Ticket to Generational Wealth?
24/7 Wall St. 2d
Own 500 Shares of Pfizer and JNJ and Here's Your Annual Dividend Income

Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income By Vandita Jadeja Published Jun 21, 11:30AM EDT Quick Read 500 shares each of PFE and...

Own 500 Shares of Pfizer and JNJ and Here's Your Annual Dividend Income
Simply Wall St 2d
How Investors May Respond To Pfizer CFO Exit Amid New Hemophilia Drug And Licensing Wins

Pfizer recently announced that Chief Financial Officer Dave Denton will leave the company on August 15, 2026, with longtime finance executive Cecile Guegan step...

How Investors May Respond To Pfizer CFO Exit Amid New Hemophilia Drug And Licensing Wins

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.